Lifelong health
belongs to
everyone

Features of My Nightingale

My Nightingale is a blood analysis service that uses a blood sample to score the risk of future lifestyle-related diseases (cardiovascular disease and type 2 diabetes). The underlying technology measures 250 blood biomarkers, including ones not measured in traditional blood tests. The biomarkers are then analyzed using a proprietary algorithm to predict future disease risks not covered by standard health check-ups or physical examinations.

Image of My Nightingale

Standard health check-up results
5 biomarkers
My Nightingale's unique results
11 biomarkers

My Nightingale detects differences in the risks of future lifestyle-related diseases even for 
people who have the same results in standard health check-ups.

Nightingale Health Score* can show a low value even for individuals with normal results in standard health check-ups.
(Overseas data)

*Overall score calculated independently in My Nightingale blood test, evaluated on a 40 to 100-point scale.

Distribution of
My Nightingale Health Scores

(1) People with A rating in the 5 results
common in the standard health check-up
(2) People with an A-rated
LDL-cholesterol

In the analysis of blood samples from a Finnish biobank, Nightingale evaluated the Health Score distributions of 1) individuals who received an A grade in the classification issued by the Japan Society of Ningen Dock for the 5 biomarkers (approximately 16 000 samples) and 2) individuals who received an A grade for their LDL-cholesterol (approximately 29 000 samples).

Nightingale
Health Score

My Nightingale results

Of the 250 biomarkers measured, 16 biomarkers particularly relevant for the risk of cardiovascular disease and type 2 diabetes are shown in the figure below. 11 of these items are not usually measured in the standard health check-up.

Standard health check-up results

5 biomarkers

Results included
in the traditional
health check-up
and My Nightingale

● HDL cholesterol
Also called the “good” cholesterol. Associated with preventing arterial stiffness.
● LDL cholesterol
Also called the “bad” cholesterol. Associated with promoting atherosclerosis.
● Non-HDL cholesterol
All cholesterol levels that trigger arterial stiffening. It is a comprehensive management index for the risk of arterial stiffening, and high levels are associated with atherosclerosis, abnormal lipid metabolism, and familial hyperlipidemia.
● Triglycerides
Accounts for the majority of body fat and is associated with obesity and lifestyle-related diseases.
● Glucose
Glucose levels in the blood. Associated with diabetes and vascular damage.

My Nightingale’s unique results

11 biomarkers

Additional unique
results included in
My Nightingale

● VLDL cholesterol
Reflects triglyceride levels as it carries triglycerides in the bloodstream.
● ApoB
Binds to LDL cholesterol and circulates in the body, thus reflecting the amount of LDL cholesterol.
● ApoA1
Binds to HDL cholesterol and circulates in the body, thus reflecting the amount of HDL cholesterol.
● Ratio of ApoB/ApoA1
Indirectly reflects the ratio of LDL/HDL cholesterol.
● GlycA
Glycoprotein acetylation. Reflects chronic inflammation.
● Percentage of omega-3
Reflects the amount of omega-3 fatty acids, which have triglyceride-lowering and other beneficial effects.
● Percentage of omega-6
Reflects the amount of omega-6 fatty acids, which have cholesterol-lowering properties.
● Percentage of monounsaturated fatty acids
High levels often reflect insulin resistance.
● Percentage of polyunsaturated fatty acids
Reflects the amount of polyunsaturated fatty acids such as omega-3 and 6 fatty acids.
● Percentage of saturated fatty acids
High levels are associated with the risk of developing type 2 diabetes and heart disease.
● Branched chain amino acid
High levels are associated with type 2 diabetes risk.

What My Nightingale reveals

By examining in detail the results that are not measured in standard health check-ups and physical examinations,
My Nightingale will not only reveal your risk of developing lifestyle-related diseases, but also provide advice on how to reduce your risk.

Risk of developing
lifestyle-related diseases

The risk of developing cardiovascular disease and type 2 diabetes within 10 years is statistically assessed.

Specific actions to take to
reduce the risk

As many as 250 blood biomarkers are examined and evaluated in detail, including ones not measured in standard blood tests. This reveals indicators and hidden information of particular problems, enabling us to define actions to be taken for improvement.